DOSSIER · 13F-HR · Q2 2026
ABG-WTT Global Life Science Capital Partners GP Ltd
$9M in tracked AUM across 2 positions as of Q2 2026.
AG
CIK 0001832108 · last filed Jun 30, 2026
AI Analysis · Q2 2026
Portfolio Overview
ABG-WTT Global Life Science Capital Partners GP Ltd reports a compact, highly concentrated long equity portfolio worth $18.68 million as of 2025-09-30. The filing lists only two positions and no trading activity during the quarter (no new, sold, increased or reduced stakes). The fund’s reported portfolio value fell 30.2% vs. the prior quarter — an absolute decline of $8.08 million (from $26.76M to $18.68M). The combination of very small number of holdings and a large quarter...
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology
Quarter at a glance — Q2 2026
Position-change comparison pending.
No quarter-over-quarter changes available.
Top 10 holdings
By portfolio weight as of Q2 2026.
Filing history
Showing 12 of 23